Zealand Pharma A/S : Interim Report for Q1 2023

Company announcement


No. 20 / 2023


Zealand Pharma Announces Financial Results for the First Quarter of 2023.
... | May 11, 2023

Related Keywords

Denmark ,Amsterdam ,Noord Holland ,Netherlands ,Boston ,Massachusetts ,United States ,Ukraine ,France ,Paris ,France General ,United Kingdom ,Copenhagen ,Køavn ,American ,Adam Steensberg ,Zealand Pharma ,David Kendall ,Novo Nordisk ,Henriette Wennicke ,Anna Krassowska ,Boehringer Ingelheim ,Danske Bank ,European Commission ,European Medicines Agency ,American Diabetes Association ,Investor Relations Corporate Communications ,Pharma Announces Financial Results ,First Quarter ,Chief Executive Officer ,Scientific Sessions ,Oberland Capital ,Chief Financial Officer ,Chief Medical Officer ,Private Securities Litigation Reform Act ,Upcoming Events ,Financial Guidance ,Investor Relations ,Corporate Communications ,Practice Conference ,Digestive Diseases Week ,Lancet Gastroenterology ,Zealand Pharmaas Stock Exchange ,News ,Information ,Press Release ,Company , 0 ,Zealand ,Dharma ,Nnounces ,Financial ,Results ,Or ,The ,First ,Quarter ,F Zeal Dk0060257814 ,